Effect of Mung Bean Sprout Powder on Quality and Nutrition of Yoghurt

In order to study the effect of germinated mung bean powder on the quality and nutrition of yogurt,different varieties of mung bean were selected in this paper,germinated mung bean sprout powder and pure milk as raw materials,Lactobacillus bulgaricus and Streptococcus thermophilus as fermentation strains,solidified germinated mung bean yoghurt was developed by single factor and orthogonal test; The contents of vitexin,isovitexin and cellulose in the germination mung bean powder were determined by high performance liquid chromatography and enzyme-weight method to explore the effects of adding germination mung bean powder on the quality and nutrition of yogurt.The results showed that the addition of germinated mung bean powder could strengthen the tissue structure of yogurt,increase the number of viable lactic acid bacteria,and give the yogurt a unique mung bean flavor; Moreover,the addition of germinated mung bean powder could enhance the antioxidant properties of yogurt,increase soluble dietary fiber,beneficial ingredients such as vitexin and isovitexin,and give yogurt physiological health functions.The best process for coagulated germination mung bean yogurt was:adding 2% germination mung bean powder,7% sucrose,0.3% CMC stabilizer,adding starter at the ratio of 1.5 g/L,and incubating at 42 ℃ for 5 hours.Under these conditions the germinated mung bean yogurt had a stable structure and good flavor and taste

Multi-Player and Multi-Choice Quantum Game

We investigate a multi-player and multi-choice quantum game. We start from two-player and two-choice game and the result is better than its classical version. Then we extend it to N-player and N-choice cases. In the quantum domain, we provide a strategy with which players can always avoid the worst outcome. Also, by changing the value of the parameter of the initial state, the probabilities for players to obtain the best payoff will be much higher that in its classical version.Comment: 4 pages, 1 figur

Experimental Gaussian Boson Sampling

Gaussian Boson sampling (GBS) provides a highly efficient approach to make use of squeezed states from parametric down-conversion to solve a classically hard-to-solve sampling problem. The GBS protocol not only significantly enhances the photon generation probability, compared to standard boson sampling with single photon Fock states, but also links to potential applications such as dense subgraph problems and molecular vibronic spectra. Here, we report the first experimental demonstration of GBS using squeezed-state sources with simultaneously high photon indistinguishability and collection efficiency. We implement and validate 3-, 4- and 5-photon GBS with high sampling rates of 832 kHz, 163 kHz and 23 kHz, respectively, which is more than 4.4, 12.0, and 29.5 times faster than the previous experiments. Further, we observe a quantum speed-up on a NP-hard optimization problem when comparing with simulated thermal sampler and uniform sampler.Comment: 12 pages, 4 figures, published online on 2nd April 201

Umbilical cord blood: A promising source for allogeneic CAR-T cells

Chimeric antigen receptor T (CAR-T) cell therapy is an effective treatment for relapsed and refractory acute lymphoblastic leukemia (R/R ALL). However, autologous CAR-T cells derived from patients with B-ALL often show poor amplification ability, exhaustion, and anergy. To overcome these limitations, allogeneic CAR-T cells may be used as effective substitutes; however, which source would be the best substitute is unclear. In this study, we compared the immunophenotype and antitumor efficacy of anti-CD19 CAR-T cells derived from healthy donor cord blood (CB), healthy donor peripheral blood (PB), and PB of B-ALL patients [PB (patient)] in vitro and NOD-Prkdcem26cd52Il2rgem26Cd22/Nju (NCG)-immunodeficient mice, respectively. The results revealed that CAR-T cells derived from healthy donor CB and PB showed a higher proportion of naive T cells and longer tumor suppression in tumor-bearing mice than those of PB (patient). PB (patient) CAR-T cells had a higher proportion of regulatory T cells (Treg cells) and released high levels of interluekin-10 (IL-10), which also suggest a poor prognosis. Thus, CAR-T cells derived from healthy donors have better antitumor efficacy than CAR-T cells derived from PB (patient), and CB may be a good source of allogeneic CAR-T cells